Alpha Centric Advisors LLC Sarepta Therapeutics, Inc. Transaction History
Alpha Centric Advisors LLC
- $97.4 Million
- Q4 2024
A detailed history of Alpha Centric Advisors LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 2,211 shares of SRPT stock, worth $251,434. This represents 0.28% of its overall portfolio holdings.
Number of Shares
2,211
Previous 18,000
87.72%
Holding current value
$251,434
Previous $2.25 Million
88.08%
% of portfolio
0.28%
Previous 1.9%
Shares
14 transactions
Others Institutions Holding SRPT
# of Institutions
525Shares Held
84.4MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.17 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.02 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$712 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$496 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$486 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.96B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...